Xenon Pharmaceuticals (XENE) Competitor Comparison
We are evaluating the key criteria listed to compare Xenon Pharmaceuticals (XENE) against its competitors in the Biotechnology industry.
Market Capitalization
49 / 368Gross Profits
236 / 278Total Revenue
296 / 300EBITDA
284 / 337Free Cashflow
274 / 352Quick Ratio
23 / 357Earnings per Share
247 / 359Dividend yield
0 / 6Total Cash
58 / 358Performance 3 years
72 / 368Performance 5 years
24 / 368Performance 10 years
34 / 368Linearity 3 years
63 / 368Linearity 5 years
334 / 368Linearity 10 years
348 / 368Total Rank
71 / 368Dividend Rank
316 / 368Valuation Rank
271 / 368Piotroski Rank
181 / 368Muliplier Rank
242 / 368Market Capitalization - XENE ranking 49 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.